Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Diamond

Showing results (1001-1010 of 1,007) with videos related to

Pageof 101
Sort By:
You have reached the last page of results.This site can display upto 1,007 results.
Proceedings of the National Academy of Sciences of the United States of America|September 2, 2021
Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaquesHannah A D King, M Gordon Joyce, Ines Lakhal-Naouar, et al.
Biorxiv : the Preprint Server for Biology|April 14, 2021
Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaquesHannah A D King, M Gordon Joyce, Ines Elakhal Naouar, et al.
Science Translational Medicine|December 16, 2021
A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primatesM Gordon Joyce, Hannah A D King, Ines Elakhal-Naouar, et al.
The Lancet. Microbe|July 14, 2021
Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological studyWilliam M Souza, Mariene R Amorim, Renata Sesti-Costa, et al.
Cell Host & Microbe|March 13, 2024
Pathophysiology of chikungunya virus infection associated with fatal outcomesWilliam M de Souza, Marcilio J Fumagalli, Shirlene T S de Lima, et al.
Nature|April 1, 2022
Defining the risk of SARS-CoV-2 variants on immune protectionMarciela M DeGrace, Elodie Ghedin, Matthew B Frieman, et al.
Biological Conservation|May 26, 2021
Global COVID-19 lockdown highlights humans as both threats and custodians of the environmentAmanda E Bates, Richard B Primack, Brandy S Biggar, et al.
Pageof 101

Showing results (1001-1010 of 1,007) with videos related to

Sort By:
Pageof 101
You have reached the last page of results.This site can display upto 1,007 results.
Proceedings of the National Academy of Sciences of the United States of America|September 2, 2021
Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaquesHannah A D King, M Gordon Joyce, Ines Lakhal-Naouar, et al.
Biorxiv : the Preprint Server for Biology|April 14, 2021
Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaquesHannah A D King, M Gordon Joyce, Ines Elakhal Naouar, et al.
Science Translational Medicine|December 16, 2021
A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primatesM Gordon Joyce, Hannah A D King, Ines Elakhal-Naouar, et al.
The Lancet. Microbe|July 14, 2021
Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological studyWilliam M Souza, Mariene R Amorim, Renata Sesti-Costa, et al.
Cell Host & Microbe|March 13, 2024
Pathophysiology of chikungunya virus infection associated with fatal outcomesWilliam M de Souza, Marcilio J Fumagalli, Shirlene T S de Lima, et al.
Nature|April 1, 2022
Defining the risk of SARS-CoV-2 variants on immune protectionMarciela M DeGrace, Elodie Ghedin, Matthew B Frieman, et al.
Biological Conservation|May 26, 2021
Global COVID-19 lockdown highlights humans as both threats and custodians of the environmentAmanda E Bates, Richard B Primack, Brandy S Biggar, et al.
Pageof 101